Adaptive Biotechnologies Corp (NASDAQ: ADPT) kicked off on November 20, 2023, at the price of $4.34, up 3.02% from the previous trading day. During the day, the shares moved up to $4.645 and dropped to $4.22 before settling in for the closing price of $4.31. Over the past 52 weeks, ADPT has traded in a range of $2.61-$10.79.
During the last 5-year period, the sales growth of Healthcare Sector giant was 38.04%. While this was happening, its average annual earnings per share was recorded 1.71%. With a float of $141.61 million, this company’s outstanding shares have now reached $143.11 million.
Let’s determine the extent of company efficiency that accounts for 790 employees. In terms of profitability, gross margin is +57.46, operating margin of -106.94, and the pretax margin is -108.13.
Adaptive Biotechnologies Corp (ADPT) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Adaptive Biotechnologies Corp is 2.18%, while institutional ownership is 94.78%. The most recent insider transaction that took place on Nov 16, was worth 1,070. In this transaction Principal Accounting Officer of this company sold 259 shares at a rate of $4.13, taking the stock ownership to the 87,305 shares. Before that another transaction happened on Aug 08, when Company’s Chief Commercial Officer, MRD sold 10,550 for $6.54, making the entire transaction worth $68,997. This insider now owns 214,808 shares in total.
Adaptive Biotechnologies Corp (ADPT) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/29/2023, the organization reported -$0.35 earnings per share (EPS), lower than consensus estimate (set at -$0.34) by -$0.01. This company achieved a net margin of -108.03 while generating a return on equity of -37.48. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1.71% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 21.60% during the next five years compared to -32.30% drop over the previous five years of trading.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Trading Performance Indicators
Take a look at Adaptive Biotechnologies Corp’s (ADPT) current performance indicators. Last quarter, stock had a quick ratio of 4.46. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.36, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.15 in one year’s time.
Technical Analysis of Adaptive Biotechnologies Corp (ADPT)
Looking closely at Adaptive Biotechnologies Corp (NASDAQ: ADPT), its last 5-days average volume was 1.75 million, which is a jump from its year-to-date volume of 1.17 million. As of the previous 9 days, the stock’s Stochastic %D was 71.03%. Additionally, its Average True Range was 0.43.
During the past 100 days, Adaptive Biotechnologies Corp’s (ADPT) raw stochastic average was set at 31.08%, which indicates a significant decrease from 68.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 132.06% in the past 14 days, which was higher than the 80.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.79, while its 200-day Moving Average is $6.87. However, in the short run, Adaptive Biotechnologies Corp’s stock first resistance to watch stands at $4.65. Second resistance stands at $4.86. The third major resistance level sits at $5.08. If the price goes on to break the first support level at $4.22, it is likely to go to the next support level at $4.01. Now, if the price goes above the second support level, the third support stands at $3.80.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Key Stats
The company with the Market Capitalisation of 642.78 million has total of 144,773K Shares Outstanding. Its annual sales at the moment are 185,310 K in contrast with the sum of -200,190 K annual income. Company’s last quarter sales were recorded 37,920 K and last quarter income was -50,300 K.